Target intelligence / Profile preview

OTU domain-containing protein 6B (OTUD6B)

Target
OTUD6B
Molecular classification
Enzyme, Cysteine protease (OTU family), Deubiquitinase
01

Overview

OTU domain-containing protein 6B is a cysteine-type deubiquitinase, part of the OTU protease family, using a conserved catalytic triad of cysteine, histidine, and aspartate. It removes ubiquitin from protein substrates, regulating their degradation, participating in cell cycle control (in B cells), protein synthesis, growth, and proteasome function. Loss-of-function mutations in humans are linked to developmental disorders with intellectual disability, seizures, and distinct limb anomalies[1][2][3][4].

Other names
OTU domain-containing protein 6BDUBA5OTUD6BOTU6B
02

Mechanism of action

Drugs hypothetically targeting OTUD6B would likely act as inhibitors or modulators of its deubiquitinating activity, affecting protein degradation and cell cycle pathways (speculative, as no approved drugs are known[2][4])

03

Biological functions

Ubiquitin-dependent regulation of protein synthesisNegative regulation of cell cycle (especially in B cells)Regulation of cell growth and proliferationProtein translation repressionProteasome assembly and function
04

Disease associations

Intellectual developmental disorder with dysmorphic featuresSeizuresDistal limb anomaliesEpilepsyPotential roles in cancer (proposed based on DUB function and cellular growth/proliferation relevance, but needs confirmation in clinical contexts)
05

Safety considerations

Potential for interference with normal cell cycle regulation, growth, and intellectual development, particularly in developing individualsMutations are associated with developmental syndromes, suggesting possible safety concerns if targeted pharmacologically

Beyond the preview

Go deeper on OTU domain-containing protein 6B (OTUD6B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTU domain-containing protein 6B (OTUD6B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call